Validation of 2 Syncope Risk Scores and Comparison With Physician Risk Estimation

• by Edward H. Suh, Carolyn Winskill, Dana L. Sacco, John DeAngelis, Daniel K. Nishijima, Jonathan Schimmel, Alan B. Storrow, Nancy E. Wood, Venkatesh Thiruganasambandamoorthy, Christopher W. Baugh, Robert E. Weiss, Marc A. Probst

• May 19, 2026

2026 ASCO Breast Cancer Highlights: PANKU-Breast02

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new results from the PANKU-Breast02 Study on a new dual-antibody drug conjugate, called izalontamab brengitecan (iza-bren), for metastatic triple-negative breast cancer.

• October 15, 2026

• 1 min

2026 ASCO Breast Cancer Highlights: BWEL

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.

• October 15, 2026

• 1 min

Factors Associated With Pediatric Health Care Professionals’ Intention to Adopt Socially Assistive Robots: Mixed Methods Study

• by Yun-Hsuan Lee, Fang-Yu Hsu, Sue-hsien Chen, Shih-Ming Chu, Chih-Yuan Yang, Feng-Hsuan Liu, Angela Shin-Yu Lien

• October 15, 2026